524 related articles for article (PubMed ID: 36759557)
41. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
42. Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses.
Hong MH; Weng IC; Li FY; Lin WH; Liu FT
J Biomed Sci; 2021 Mar; 28(1):16. PubMed ID: 33663512
[TBL] [Abstract][Full Text] [Related]
43. Rho GTPase Rac1: molecular switch within the galectin network and for N-glycan α2,6-sialylation/O-glycan core 1 sialylation in colon cancer in vitro.
André S; Singh T; Lacal JC; Smetana K; Gabius HJ
Folia Biol (Praha); 2014; 60(3):95-107. PubMed ID: 25056432
[TBL] [Abstract][Full Text] [Related]
44. Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition.
Delaine T; Collins P; MacKinnon A; Sharma G; Stegmayr J; Rajput VK; Mandal S; Cumpstey I; Larumbe A; Salameh BA; Kahl-Knutsson B; van Hattum H; van Scherpenzeel M; Pieters RJ; Sethi T; Schambye H; Oredsson S; Leffler H; Blanchard H; Nilsson UJ
Chembiochem; 2016 Sep; 17(18):1759-70. PubMed ID: 27356186
[TBL] [Abstract][Full Text] [Related]
45. Vascular galectins: regulators of tumor progression and targets for cancer therapy.
Thijssen VL; Rabinovich GA; Griffioen AW
Cytokine Growth Factor Rev; 2013 Dec; 24(6):547-58. PubMed ID: 23942184
[TBL] [Abstract][Full Text] [Related]
46. Galectins: structure, function and therapeutic potential.
Yang RY; Rabinovich GA; Liu FT
Expert Rev Mol Med; 2008 Jun; 10():e17. PubMed ID: 18549522
[TBL] [Abstract][Full Text] [Related]
47. Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.
Sethi A; Sanam S; Alvala M
Eur J Med Chem; 2021 Oct; 222():113561. PubMed ID: 34146913
[TBL] [Abstract][Full Text] [Related]
48. The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer.
Manero-Rupérez N; Martínez-Bosch N; Barranco LE; Visa L; Navarro P
Cells; 2020 Mar; 9(3):. PubMed ID: 32168866
[TBL] [Abstract][Full Text] [Related]
49. Galectin-Binding O-Glycosylations as Regulators of Malignancy.
Dimitroff CJ
Cancer Res; 2015 Aug; 75(16):3195-202. PubMed ID: 26224120
[TBL] [Abstract][Full Text] [Related]
50. Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.
Stegmayr J; Lepur A; Kahl-Knutson B; Aguilar-Moncayo M; Klyosov AA; Field RA; Oredsson S; Nilsson UJ; Leffler H
J Biol Chem; 2016 Jun; 291(25):13318-34. PubMed ID: 27129206
[TBL] [Abstract][Full Text] [Related]
51. Galectin-Carbohydrate Interactions in Biomedicine and Biotechnology.
Laaf D; Bojarová P; Elling L; Křen V
Trends Biotechnol; 2019 Apr; 37(4):402-415. PubMed ID: 30413271
[TBL] [Abstract][Full Text] [Related]
52. Examining galectin binding specificity using glycan microarrays.
Arthur CM; Rodrigues LC; Baruffi MD; Sullivan HC; Heimburg-Molinaro J; Smith DF; Cummings RD; Stowell SR
Methods Mol Biol; 2015; 1207():115-31. PubMed ID: 25253137
[TBL] [Abstract][Full Text] [Related]
53. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.
Langbein S; Brade J; Badawi JK; Hatzinger M; Kaltner H; Lensch M; Specht K; André S; Brinck U; Alken P; Gabius HJ
Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590
[TBL] [Abstract][Full Text] [Related]
54. Role of galectins in lung cancer.
Chang WA; Tsai MJ; Kuo PL; Hung JY
Oncol Lett; 2017 Nov; 14(5):5077-5084. PubMed ID: 29113148
[TBL] [Abstract][Full Text] [Related]
55. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
[TBL] [Abstract][Full Text] [Related]
56. Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling.
Garner OB; Baum LG
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1472-7. PubMed ID: 19021578
[TBL] [Abstract][Full Text] [Related]
57. Physical tuning of galectin-3 signaling.
Farhadi SA; Liu R; Becker MW; Phelps EA; Hudalla GA
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33941700
[TBL] [Abstract][Full Text] [Related]
58. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
[TBL] [Abstract][Full Text] [Related]
59. Glycobiology of developing chicken kidney: Profiling the galectin family and selected β-galactosides.
Manning JC; García Caballero G; Ludwig AK; Kaltner H; Sinowatz F; Gabius HJ
Anat Rec (Hoboken); 2021 Aug; 304(8):1597-1628. PubMed ID: 33119962
[TBL] [Abstract][Full Text] [Related]
60. Theoretical investigation on the glycan-binding specificity of Agrocybe cylindracea galectin using molecular modeling and molecular dynamics simulation studies.
Parasuraman P; Murugan V; Selvin JF; Gromiha MM; Fukui K; Veluraja K
J Mol Recognit; 2015 Sep; 28(9):528-38. PubMed ID: 25760468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
